[18F]Fluorodeoxyglucose positron emission tomography for outcome prediction of mammalian target of rapamycin inhibitor therapy

J Clin Oncol. 2010 May 20;28(15):e236-7; author reply e238. doi: 10.1200/JCO.2009.26.6866. Epub 2010 Feb 22.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibiotics, Antineoplastic / therapeutic use*
  • Disease Progression
  • Disease-Free Survival
  • Fluorine Radioisotopes*
  • Fluorodeoxyglucose F18*
  • Humans
  • Intracellular Signaling Peptides and Proteins / metabolism*
  • Neoplasms / diagnostic imaging*
  • Neoplasms / drug therapy
  • Neoplasms / metabolism
  • Positron-Emission Tomography
  • Protein Serine-Threonine Kinases / metabolism*
  • Radiopharmaceuticals*
  • Sirolimus / therapeutic use*
  • TOR Serine-Threonine Kinases
  • Treatment Outcome

Substances

  • Antibiotics, Antineoplastic
  • Fluorine Radioisotopes
  • Intracellular Signaling Peptides and Proteins
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • MTOR protein, human
  • Protein Serine-Threonine Kinases
  • TOR Serine-Threonine Kinases
  • Sirolimus